Recruiting

Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

Sponsor:

Dutch Childhood Oncology Group

Code:

NCT00550992

Conditions

Leukemia

Eligibility Criteria

Sex: All

Age: 0 - 1

Healthy Volunteers: Not accepted

Interventions

anti-thymocyte globulin

asparaginase

busulfan

cyclophosphamide

cyclosporine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Dutch Childhood Oncology Group on 2019-07-30.